2018
DOI: 10.7150/jbji.23423
|View full text |Cite
|
Sign up to set email alerts
|

Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections

Abstract: Traumatic orthopedic injuries, particularly extremity wounds, are a significant cause of morbidity. Despite prophylactic antibiotic treatment and surgical intervention, persistent infectious complications can and do occur. Persistent bacterial infections are often caused by biofilms, communities of antibiotic tolerant bacteria encased within a matrix. The structural and metabolic differences in this mode of growth make treatment difficult. Herein, we describe both established and novel, experimental treatments… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(25 citation statements)
references
References 218 publications
0
25
0
Order By: Relevance
“…In other words, mixed infections involve complex interactions between facultative bacteria and strict anaerobes, many of which maintain intrinsic pathogenicity [33]. Based on these facts, several evidences and reports including ours encourages the use of combination therapy regimens as against monotherapy for treatment of wound infections [33][34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…In other words, mixed infections involve complex interactions between facultative bacteria and strict anaerobes, many of which maintain intrinsic pathogenicity [33]. Based on these facts, several evidences and reports including ours encourages the use of combination therapy regimens as against monotherapy for treatment of wound infections [33][34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…The excellent ability of PEUA-PEG 30 to reduce bacterial adhesion and biofilm formation is definitely related to its higher bulk and surface hydrophilicity which also presumably involve the exposition of PEG chains at the material/water interface, as shown by dynamic contact angle analysis. However, since the polymer does not completely inhibit bacterial adhesion, such a system should be used in combination with other anti-biofilm molecules, to maximize its performance [15,57,58]. Unexpectedly, the mechanical resistance of the PEG-functionalized polymer also improved because the presence of PEG, with benefits for the application.…”
Section: Polymermentioning
confidence: 99%
“…For instance, defects in MDR EP activity reduced the biofilm formation and thus, EP inhibitors have been employed as a promising biofilm inhibition approach for strains of E. coli and Klebsiella [102], Salmonella [103], P. aeruginosa and S. aureus [104]. However, certain other reports show that despite the elimination of planktonic cells through pharmacological intervention, the sessile forms are resistant and continue to proliferate within the biofilm [105]. This is more of prominence on abiotic surfaces [95], such as catheters [106], contact lenses [107] and prosthetic cardiac valves [108].…”
Section: Biofilmsmentioning
confidence: 99%